γ-secretase limits the inflammatory response through the processing of LRP1

Science Signaling

Volumn 1, Issue 47, 2008, Pages

  Zurhove, Kai ^a   Nakajima, Chikako ^a   Herz, Joachim ^a,b   Bock, Hans H ^a   May, Petra ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 3; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PROTEASOME; SECRETASE;

ACTIVE TRANSPORT; ANIMAL; ARTICLE; CYTOLOGY; FIBROBLAST; GENETIC TRANSCRIPTION; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE;

ACTIVE TRANSPORT, CELL NUCLEUS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; FIBROBLASTS; INFLAMMATION; INTERFERON REGULATORY FACTOR-3; LDL-RECEPTOR RELATED PROTEIN 1; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION, GENETIC;

EID: 58749110564     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.1164263     Document Type: Article

References (56)

1. A. L. Parks, D. Curtis, Presenilin diversifies its portfolio. Trends Genet. 23, 140-150 (2007).
2. M. Ehebauer, P. Hayward, A. Martinez-Arias, Notch signaling pathway. Sci. STKE 2006, cm7 (2006).
3. C. Y. Ni, M. P. Murphy, T. E. Golde, G. Carpenter, γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 2179-2181 (2001).
4. S. P. Sardi, J. Murtie, S. Koirala, B. A. Patten, G. Corfas, Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127, 185-197 (2006).
5. J. Herz, D. K. Strickland, LRP: A multifunctional scavenger and signaling receptor. J. Clin. Invest. 108, 779-784. (2001).
6. P. Boucher, M. Gotthardt, W. P. Li, R. G. Anderson, J. Herz, LRP: Role in vascular wall integrity and protection from atherosclerosis. Science 300, 329-332 (2003).
7. P. Boucher, W. P. Li, R. L. Matz, Y. Takayama, J. Auwerx, R. G. Anderson, J. Herz, LRP1 functions as an atheroprotective integrator of TGFβ and PDGF signals in the vascular wall: Implications for Marfan syndrome. PLoS ONE 2, e448 (2007).
8. M. Yepes, M. Sandkvist, E. G. Moore, T. H. Bugge, D. K. Strickland, D. A. Lawrence, Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 112, 1533-1540 (2003).
9. P. May, A. Rohlmann, H. H. Bock, K. Zurhove, J. D. Marth, E. D. Schomburg, J. L. Noebels, U. Beffert, J. D. Sweatt, E. J. Weeber, J. Herz, Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol. Cell. Biol. 24, 8872-8883 (2004).
10. S. J. Gardai, K. A. McPhillips, S. C. Frasch, W. J. Janssen, A. Starefeldt, J. E. Murphy- Ullrich, D. L. Bratton, P. A. Oldenborg, M. Michalak, P. M. Henson, Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321-334 (2005).
11. S. J. Gardai, Y. Q. Xiao, M. Dickinson, J. A. Nick, D. R. Voelker, K. E. Greene, P. M. Henson, By binding SIRPa or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115, 13-23 (2003).
12. I. Jutras, A. Laplante, J. Boulais, S. Brunet, G. Thinakaran, M. Desjardins, γ-secretase is a functional component of phagosomes. J. Biol. Chem. 280, 36310-36317 (2005).
13. P. May, Y. K. Reddy, J. Herz, Proteolytic processing of low density lipoprotein receptor- related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277, 18736-18743 (2002).
14. Y. Ogata, M. A. Pratta, H. Nagase, E. C. Arner, Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1 β and a protein kinase C activator. Exp. Cell. Res. 201, 245-249 (1992).
15. A. M. Manicone, J. K. McGuire, Matrix metalloproteinases as modulators of inflammation. Semin. Cell Dev. Biol. 19, 34-41 (2008).
16. S. I. Miller, R. K. Ernst, M. W. Bader, LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3, 36-46 (2005).
17. E. M. Palsson-McDermott, L. A. O'Neill, Signal transduction by the lipopolysaccharide receptor, Toll-like receptor 4. Immunology 113, 153-162 (2004).
18. M. Fujihara, S. Wakamoto, T. Ito, M. Muroi, T. Suzuki, H. Ikeda, K. Ikebuchi, Lipopolysaccharide-triggered desensitization of TNF-A mRNA expression involves lack of phosphorylation of Iκa in a murine macrophage-like cell line, P388D1. J. Leukoc. Biol. 68, 267-276 (2000).
19. K. P. Kumar, K. M. McBride, B. K. Weaver, C. Dingwall, N. C. Reich, Regulated nuclearcytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol. Cell. Biol. 20, 4159-4168 (2000).
20. T. Saitoh, A. Tun-Kyi, A. Ryo, M. Yamamoto, G. Finn, T. Fujita, S. Akira, N. Yamamoto, K. P. Lu, S. Yamaoka, Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 7, 598-605 (2006).
21. K. C. Chin, P. Cresswell, Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc. Natl. Acad. Sci. U.S.A. 98, 15125-15130 (2001).
22. D. Kang, H. Jiang, Q. Wu, S. Pestka, P. B. Fisher, Cloning and characterization of human ubiquitin-processing protease-43 from terminally differentiated human melanoma cells using a rapid subtraction hybridization protocol RaSH. Gene 267, 233-242 (2001).
23. C. G. Lee, W. E. O'Brien, A unique member of the thymidylate kinase family that is induced during macrophage activation. J. Immunol. 154, 6094-6102 (1995).
24. O. Malakhova, M. Malakhov, C. Hetherington, D. E. Zhang, Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3. J. Biol. Chem. 277, 14703-14711 (2002).
25. P. S. Olofsson, K. Jatta, D. Wagsater, S. Gredmark, U. Hedin, G. Paulsson-Berne, C. Soderberg-Naucler, G. K. Hansson, A. Sirsjo, The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler. Thromb. Vasc. Biol. 25, e113-e116 (2005).
26. C. Yan, P. B. Sehgal, I. Tamm, Signal transduction pathways in the induction of 2',5'- oligoadenylate synthetase gene expression by interferon alpha/beta. Proc. Natl. Acad. Sci. U.S.A. 86, 2243-2247 (1989).
27. P. Boucher, P. Liu, M. Gotthardt, T. Hiesberger, R. G. Anderson, J. Herz, Plateletderived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J. Biol. Chem. 277, 15507-15513 (2002).
28. S. S. Huang, T. Y. Ling, W. F. Tseng, Y. H. Huang, F. M. Tang, S. M. Leal, J. S. Huang, Cellular growth inhibition by IGFBP-3 and TGF-β1 requires LRP-1. FASEB J. 17, 2068-2081 (2003).
29. E. Loukinova, S.Ranganathan, S. Kuznetsov, N. Gorlatova, M. M. Migliorini, D. Loukinov, P. G. Ulery, I. Mikhailenko, D. A. Lawrence, D. K. Strickland, Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor- related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF. J. Biol. Chem. 277, 15499-15506 (2002).
30. A. Kinoshita, T. Shah, M. M. Tangredi, D. K. Strickland, B. T. Hyman, The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J. Biol. Chem. 278, 41182-41188 (2003).
31. P. May, H. H. Bock, J. Nimpf, J. Herz, Differential glycosylation regulates processing of lipoprotein receptors by γ-secretase. J. Biol. Chem. 278, 37386-37392 (2003).
32. K. A. Quinn, V. J. Pye, Y. P. Dai, C. N. Chesterman, D. A. Owensby, Characterization of the soluble form of the low density lipoprotein receptor-related protein (LRP). Exp. Cell Res. 251, 433-441 (1999).
33. A. Castrillo, D. J. Pennington, F. Otto, P. J. Parker, M. J. Owen, L. Bosca, Protein kinase Ce is required for macrophage activation and defense against bacterial infection. J. Exp. Med. 194, 1231-1242 (2001).
34. C. Wietek, S. M. Miggin, C. A. Jefferies, L. A. O'Neill, Interferon regulatory factor-3- mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NFκB. J. Biol. Chem. 278, 50923-50931 (2003).
35. A. Kawamura, D. Baitsch, R. Telgmann, R. Feuerborn, G. Weissen-Plenz, C. Hagedorn, K. Saku, S. M. Brand-Herrmann, A. von Eckardstein, G. Assmann, J. R. Nofer, Apolipoprotein E interrupts interleukin-1β signaling in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 27, 1610-1617 (2007).
36. G. Yu, A. H. Rux, P. Ma, K. Bdeir, B. S. Sachais, Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF- κB-dependent manner. Blood 105, 3545-3551 (2005).
37. A. Gaultier, S. Arandjelovic, S. Niessen, C. D. Overton, M. F. Linton, S. Fazio, W. M. Campana, B. F. Cravatt 3rd, S. L. Gonias, Regulation of tumor necrosis factor receptor- 1 and the IKK-NF-κB pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor. Blood 111, 5316-5325 (2008).
38. S. Ogawa, J. Lozach, C. Benner, G. Pascual, R. K. Tangirala, S. Westin, A. Hoffmann, S. Subramaniam, M. David, M. G. Rosenfeld, C. K. Glass, Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707-721 (2005).
39. S. L. Foster, D. C. Hargreaves, R. Medzhitov, Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972-978 (2007).
40. P. May, J. Herz, H. H. Bock, Molecular mechanisms of lipoprotein receptor signalling. Cell Mol. Life Sci. 62, 2325-2338. (2005).
41. W. F. Tseng, S. S. Huang, J. S. Huang, LRP-1/TβR-V mediates TGF-β1-induced growth inhibition in CHO cells. FEBS Lett. 562, 71-78 (2004).
42. A. Zilberberg, A. Yaniv, A. Gazit, The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway. J. Biol. Chem. 279, 17535-17542 (2004).
43. L. Hu, L. S. Boesten, P. May, J. Herz, N. Bovenschen, M. V. Huisman, J. F. Berbee, L. M. Havekes, B. J. van Vlijmen, J. T. Tamsma, Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice. Arterioscler. Thromb. Vasc. Biol. 26, 2710-2715 (2006).
44. C. D. Overton, P. G. Yancey, A. S. Major, M. F. Linton, S. Fazio, Deletion of macrophage LDL receptor-related protein increases atherogenesis in the mouse. Circ. Res. 100, 670-677 (2007).
45. J. S. Welch, M. Ricote, T. E. Akiyama, F. J. Gonzalez, C. K. Glass, PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages. Proc. Natl. Acad. Sci. U.S.A. 100, 6712-6717 (2003).
46. R. Polavarapu, J. An, C. Zhang, M. Yepes, Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death. Am. J. Pathol. 172, 1355-1362 (2008).
47. Y. Imai, K. Kuba, G. G. Neely, R. Yaghubian-Malhami, T. Perkmann, G. van Loo, M. Ermolaeva, R. Veldhuizen, Y. H. Leung, H. Wang, H. Liu, Y. Sun, M. Pasparakis, M. Kopf, C. Mech, S. Bavari, J. S. Peiris, A. S. Slutsky, S. Akira, M. Hultqvist, R. Holmdahl, J. Nicholls, C. Jiang, C. J. Binder, J. M. Penninger, Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235-249 (2008).
48. D. J. Selkoe, Alzheimer's disease: Genes, proteins, and therapy. Physiol. Rev. 81, 741-766 (2001).
49. J. Herz, U. Hamann, S. Rogne, O. Myklebost, H. Gausepohl, K. K. Stanley, Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7, 4119-4127 (1988).
50. M. Mahadevappa, J. A. Warrington, A high-density probe array sample preparation method using 10- to 100-fold fewer cells. Nat. Biotechnol. 17, 1134-1136 (1999).
51. H. D. VanGuilder, K. E. Vrana, W. M. Freeman, Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44, 619-626 (2008).
52. A. Rohlmann, M. Gotthardt, T. E. Willnow, R. E. Hammer, J. Herz, Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat. Biotechnol. 14, 1562-1565 (1996).
53. B. E. Clausen, C. Burkhardt, W. Reith, R. Renkawitz, I. Forster, Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265-277 (1999).
54. H. M. Shin, L. M. Minter, O. H. Cho, S. Gottipati, A. H. Fauq, T. E. Golde, G. E. Sonenshein, B. A. Osborne, Notch1 augments NF-κB activity by facilitating its nuclear retention. EMBO J. 25, 129-138 (2006).
55. A. F. McGettrick, E. K. Brint, E. M. Palsson-McDermott, D. C. Rowe, D. T. Golenbock, N. J. Gay, K. A. Fitzgerald, L. A. O'Neill, Trif-related adapter molecule is phosphorylated by PKCe during Toll-like receptor 4 signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 9196-9201 (2006).
56. K. Zurhove, C. Nakajima, J. Herz, H. H. Bock, P. May, γ-Secretase limits the inflammatory response through the processing of LRP1. Sci. Signal. 1, ra15 (2008).